SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0000950116-04-000481
Filing Date
2004-02-12
Accepted
2004-02-12 16:31:13
Documents
5
Effectiveness Date
2004-02-12

Document Format Files

Seq Description Document Type Size
1 S-8 POS s8pos.txt S-8 POS 11590
3 EXHIBIT 4.1 ex4-1.txt EX-4 37303
4 EXHIBIT 5 ex5.txt EX-5 1919
5 EXHIBIT 23.1.1 ex23-11.txt EX-23 566
6 EXHIBIT 23.1.2 ex23-12.txt EX-23 659
  Complete submission text file 0000950116-04-000481.txt   53987
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-88026 | Film No.: 04592074
SIC: 2834 Pharmaceutical Preparations